A single center open-label uncontrolled study to investigate tumour response and vascularization changes in neoadjuvant therapy with BAY 43-9006 single agent therapy in patients with operable renal ce...

Update Il y a 4 ans
Reference: ISRCTN46317673

A single center open-label uncontrolled study to investigate tumour response and vascularization changes in neoadjuvant therapy with BAY 43-9006 single agent therapy in patients with operable renal cell cancer

Woman and Man

Extract

Not provided at time of registration


Inclusion criteria

  • Renal Cell Cancer

Links